PSMA-Directed Theranostics in Prostate Cancer
Following lung cancer, prostate cancer is the leading cause of cancer death in men. High-risk localized tumor burden or metastatic disease often progresses, refractory to initial treatment regimens. There is ongoing development of technology to appropriately identify high-risk patients, stage them c...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2025-07-01
|
| シリーズ: | Biomedicines |
| 主題: | |
| オンライン･アクセス: | https://www.mdpi.com/2227-9059/13/8/1837 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|